نتایج جستجو برای: warfarin reversal

تعداد نتایج: 44044  

Journal: :Vascular Health and Risk Management 2006
Shir-Jing Ho Tim A Brighton

Warfarin sodium is an effective oral anticoagulant drug. However, warfarin has a narrow therapeutic window with significant risks of hemorrhage at therapeutic concentrations. Dosing is difficult and requires frequent monitoring. New oral anticoagulant agents are required to improve current anticoagulant therapy. Furthermore, while warfarin is effective in venous disease, it does not provide mor...

Journal: :Journal of the Saudi Heart Association 2016
Abdulla Shehab Asim Ahmed Elnour Akshaya Srikanth Bhagavathula Pınar Erkekoglu Farah Hamad Saif Al Nuaimi Ali Al Shamsi Iman Mukhtar AbdElrazek M Ali AbdElrazek Aeshal Al Suwaidi Mahmoud Abu Mandil Mohamed Baraka Adel Sadik Khalid Saraan Naama M S Al Kalbani Alaa AbdulAziz Mahmood Yazan Barqawi Mohammed Al Hajjar Omer Abdulla Shehab Abdulla Al Amoodi Sahar Asim Rauda Abdulla Cristina Sanches Giraud El Mutasim Ahmed Zohdi Abu Shaaban Ahmed Eltayeb Yousif Ahmed Eltayeb

The last 70 years of Warfarin use has been associated with extreme problems. The Novel Oral Anticoagulants (NOACs) are not well utilized in patients with Atrial Fibrillation (AF). We thought to excavate the clinical utility of NOACs and provide some insights into their usefulness as suitable alternatives to Warfarin. Methods: The main objective is to raise awareness of clinicians regarding the ...

Journal: :Circulation 2014
Ammar Majeed Hun-Gyu Hwang Stuart J Connolly John W Eikelboom Michael D Ezekowitz Lars Wallentin Martina Brueckmann Mandy Fraessdorf Salim Yusuf Sam Schulman

We thank Hifumi et al for their comments on our article. 1 It is important to recognize that treatment of major bleeding on warfarin in the 5 phase III trials was according to local hospital guidelines and protocols, which are generally based on international recommendations. 2 The low reversal rate of warfarin is surprising but reflects the way warfarin-associated bleeding was managed at the e...

Journal: :International journal of clinical and experimental medicine 2015
Secgin Soyuncu Savas Aslan Halil Mutlu Firat Bektas

INTRODUCTION Prothrombin Complex Concentrate (PCC) for reversal of warfarin is the main therapeutic option in cases of life-threatening bleeding. Aim of the study was to investigate for using 4-factor PCC brought to the therapeutic levels of International Normalized Ratio (INR) values in cases of life-threatening bleeding in Emergency Department. METHODS This retrospective cohort study was pe...

Journal: :Stroke 2012
Frieder Schlunk Elizabeth M Van Cott Kazuhide Hayakawa Waltraud Pfeilschifter Eng H Lo Christian Foerch

BACKGROUND AND PURPOSE Based on an experimental model of warfarin-associated intracerebral hemorrhage, we investigated whether the rapid reversal of anticoagulation using prothrombin complex concentrates (PCC) or recombinant activated coagulation factor VII (rFVIIa) reduces hematoma volume. METHODS Mice were orally pretreated with warfarin (2 mg/kg). Intracerebral hemorrhage was induced by co...

Journal: :research in molecular medicine 0
reyhaneh kameli biology department, islamic azad university of pharmaceutical sciences, tehran, iran mandana hasanzad medical sciences research center, tehran medical branch, islamic azad university, tehran, iran zahra tahmasebi fard department of biology, roudehen branch, islamic azad university, roudehen, iran mojgan babanejad cardiogenetics research center, shahid rajaie cardiovascular medical & research center, tehran, iran mahdieh imeni biology department, islamic azad university of pharmaceutical sciences, tehran, iran lotfollah feizi barnaji cardiogenetics research center, shahid rajaie cardiovascular medical & research center, tehran, iran

background: warfarin is a common anticoagulant drug that has a narrow therapeutic index; higher dose causes excessive bleeding and lower dose leads to cerebrovascular clotting and stroke in patients. genetic factors that have been associated with warfarin response are the genes of cytochrome p450 2c9 (cyp2c9), which metabolize the more active s-enantiomer of warfarin, and vitamin k epoxide redu...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید